Spain: medtech debt down, but long road remains
This article was originally published in Clinica
Public sector debt to Spain’s medical technology suppliers edged down by a further 9.12% in the first two months of this year, according to data just released by industry association Fenin. But with the outstanding debt still at a substantial €2.55 billion ($3.28 billion), there is much work to do.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.